ArticleBMJ open respiratory research2023

Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).

Luca Richeldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.